131 related articles for article (PubMed ID: 21841752)
1. Review: lapatinib in metastatic colorectal cancer-another strategy for disease control?
Kenny LM; Lam EW
Clin Adv Hematol Oncol; 2011 Jun; 9(6):500-1. PubMed ID: 21841752
[No Abstract] [Full Text] [Related]
2. Activity of oxaliplatin plus capecitabine (CapeOx) with lapatinib for metastatic colorectal cancer: results from two patients treated on a clinical study.
Mohammed TA; Dennie T; Holen KD
Clin Adv Hematol Oncol; 2011 Jun; 9(6):492-500. PubMed ID: 21841751
[No Abstract] [Full Text] [Related]
3. The use cetuximab after oxaliplatin-based chemotherapy in a patient with metastatic colorectal cancer.
Malik Z; Eng C
Clin Adv Hematol Oncol; 2007 Jan; 5(1 Suppl 1):4-7. PubMed ID: 17491584
[No Abstract] [Full Text] [Related]
4. Liver metastases of colorectal cancer: medical treatments.
Pasetto LM; Rossi E; Monfardini S
Anticancer Res; 2003; 23(5b):4245-56. PubMed ID: 14666634
[TBL] [Abstract][Full Text] [Related]
5. How to optimize the effect of 5-fluorouracil modulated therapy in advanced colorectal cancer.
Ragnhammar P; Blomgren H
Med Oncol; 1995 Sep; 12(3):187-201. PubMed ID: 8852401
[No Abstract] [Full Text] [Related]
6. Chemotherapy in metastatic colorectal cancer.
Kelly C; Cassidy J
Surg Oncol; 2007 Jul; 16(1):65-70. PubMed ID: 17521906
[TBL] [Abstract][Full Text] [Related]
7. Radiologic and Genomic Evolution of Individual Metastases during HER2 Blockade in Colorectal Cancer.
Siravegna G; Lazzari L; Crisafulli G; Sartore-Bianchi A; Mussolin B; Cassingena A; Martino C; Lanman RB; Nagy RJ; Fairclough S; Rospo G; Corti G; Bartolini A; Arcella P; Montone M; Lodi F; Lorenzato A; Vanzati A; Valtorta E; Cappello G; Bertotti A; Lonardi S; Zagonel V; Leone F; Russo M; Balsamo A; Truini M; Di Nicolantonio F; Amatu A; Bonazzina E; Ghezzi S; Regge D; Vanzulli A; Trusolino L; Siena S; Marsoni S; Bardelli A
Cancer Cell; 2018 Jul; 34(1):148-162.e7. PubMed ID: 29990497
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant treatment of unresectable liver metastases from colorectal cancer.
Chua YJ; Cunningham D
Clin Colorectal Cancer; 2006 Mar; 5(6):405-12. PubMed ID: 16635279
[TBL] [Abstract][Full Text] [Related]
9. Reduced-dose combination chemotherapy (S-1 plus oxaliplatin) versus full-dose monotherapy (S-1) in older vulnerable patients with metastatic colorectal cancer (NORDIC9): a randomised, open-label phase 2 trial.
Winther SB; Liposits G; Skuladottir H; Hofsli E; Shah CH; Poulsen LØ; Ryg J; Osterlund P; Berglund Å; Qvortrup C; Glimelius B; Sorbye H; Pfeiffer P
Lancet Gastroenterol Hepatol; 2019 May; 4(5):376-388. PubMed ID: 30852136
[TBL] [Abstract][Full Text] [Related]
10. Trichomegaly and poliosis of the eyelashes during cetuximab treatment of metastatic colorectal cancer.
Rodriguez NA; Ascaso FJ
J Clin Oncol; 2011 Jun; 29(18):e532-3. PubMed ID: 21483009
[No Abstract] [Full Text] [Related]
11. Propensity Score Analysis of Regorafenib Versus Trifluridine/Tipiracil in Patients with Metastatic Colorectal Cancer Refractory to Standard Chemotherapy (REGOTAS): A Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study.
Moriwaki T; Fukuoka S; Taniguchi H; Takashima A; Kumekawa Y; Kajiwara T; Yamazaki K; Esaki T; Makiyama C; Denda T; Satake H; Suto T; Sugimoto N; Enomoto M; Ishikawa T; Kashiwada T; Sugiyama M; Komatsu Y; Okuyama H; Baba E; Sakai D; Watanabe T; Tamura T; Yamashita K; Gosho M; Shimada Y
Oncologist; 2018 Jan; 23(1):7-15. PubMed ID: 28894015
[TBL] [Abstract][Full Text] [Related]
12. Hepatic arterial infusion of chemotherapy for metastatic colorectal cancer.
Conroy T; Marchal F; Briançon S
N Engl J Med; 2000 May; 342(20):1525; author reply 1526-7. PubMed ID: 10819650
[No Abstract] [Full Text] [Related]
13. Hepatic arterial infusion of chemotherapy for metastatic colorectal cancer.
Atkins CD
N Engl J Med; 2000 May; 342(20):1524-5; author reply 1526-7. PubMed ID: 10819649
[No Abstract] [Full Text] [Related]
14. ASO Author Reflections: Fong's Score in the Era of Modern Strategies for Metastatic Colorectal Cancer.
Turpin A; Hebbar M
Ann Surg Oncol; 2020 Mar; 27(3):886. PubMed ID: 31720930
[No Abstract] [Full Text] [Related]
15. Hepatic arterial infusion of chemotherapy for metastatic colorectal cancer.
Venook AP; Althaus B; Warren RS
N Engl J Med; 2000 May; 342(20):1524; author reply 1526-7. PubMed ID: 10819648
[No Abstract] [Full Text] [Related]
16. Canities--reversal with chemotherapy.
Babu KG; Rasheshyam D; Lalitha N
J Assoc Physicians India; 1995 Aug; 43(8):577. PubMed ID: 8772986
[No Abstract] [Full Text] [Related]
17. [Ambulatory chemotherapy schedule for metastatic colorectal cancer].
Watine J; Soulage C
Presse Med; 2001 Jan; 30(1):35. PubMed ID: 11210587
[No Abstract] [Full Text] [Related]
18. Molecular subtypes of metastatic colorectal cancer are associated with patient response to irinotecan-based therapies.
Del Rio M; Mollevi C; Bibeau F; Vie N; Selves J; Emile JF; Roger P; Gongora C; Robert J; Tubiana-Mathieu N; Ychou M; Martineau P
Eur J Cancer; 2017 May; 76():68-75. PubMed ID: 28284171
[TBL] [Abstract][Full Text] [Related]
19. [Home chemotherapy and outpatient treatment for metastatic colorectal cancer].
Sasaki K; Takasaka H; Nishikawa N; Yoshikawa T; Hirata K
Nihon Rinsho; 2003 Sep; 61 Suppl 7():333-7. PubMed ID: 14574906
[No Abstract] [Full Text] [Related]
20. Metastatic colorectal cancer.
Bouche O; Conroy T; Michel P; Penna C; Tournigand C
Gastroenterol Clin Biol; 2006 Sep; 30 Spec No 2():2S30-2S42. PubMed ID: 17151561
[No Abstract] [Full Text] [Related]
[Next] [New Search]
